These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19161986)

  • 1. The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil).
    De Clercq E
    Biochem Pharmacol; 2009 Jun; 77(11):1655-64. PubMed ID: 19161986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers.
    De Clercq E
    Pharmacol Ther; 2010 Dec; 128(3):509-18. PubMed ID: 20826182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.
    Pusic I; DiPersio JF
    Curr Opin Hematol; 2010 Jul; 17(4):319-26. PubMed ID: 20473162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma.
    Steinberg M; Silva M
    Clin Ther; 2010 May; 32(5):821-43. PubMed ID: 20685493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent.
    Cashen AF; Nervi B; DiPersio J
    Future Oncol; 2007 Feb; 3(1):19-27. PubMed ID: 17280498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.
    Devine SM; Flomenberg N; Vesole DH; Liesveld J; Weisdorf D; Badel K; Calandra G; DiPersio JF
    J Clin Oncol; 2004 Mar; 22(6):1095-102. PubMed ID: 15020611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved mobilization of peripheral blood CD34+ cells and dendritic cells by AMD3100 plus granulocyte-colony-stimulating factor in non-Hodgkin's lymphoma patients.
    Gazitt Y; Freytes CO; Akay C; Badel K; Calandra G
    Stem Cells Dev; 2007 Aug; 16(4):657-66. PubMed ID: 17784839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.
    Uy GL; Rettig MP; Cashen AF
    Expert Opin Biol Ther; 2008 Nov; 8(11):1797-804. PubMed ID: 18847313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.
    Hess DA; Bonde J; Craft TP; Wirthlin L; Hohm S; Lahey R; Todt LM; Dipersio JF; Devine SM; Nolta JA
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):398-411. PubMed ID: 17382247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100.
    De Clercq E
    Mini Rev Med Chem; 2005 Sep; 5(9):805-24. PubMed ID: 16178723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis.
    Paganessi LA; Walker AL; Tan LL; Holmes I; Rich E; Fung HC; Christopherson KW
    Exp Hematol; 2011 Mar; 39(3):384-90. PubMed ID: 21168468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can every patient be mobilized?
    DiPersio JF
    Best Pract Res Clin Haematol; 2010 Dec; 23(4):519-23. PubMed ID: 21130416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.
    Larochelle A; Krouse A; Metzger M; Orlic D; Donahue RE; Fricker S; Bridger G; Dunbar CE; Hematti P
    Blood; 2006 May; 107(9):3772-8. PubMed ID: 16439684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plerixafor: a peripheral blood stem cell mobilizer.
    Kessans MR; Gatesman ML; Kockler DR
    Pharmacotherapy; 2010 May; 30(5):485-92. PubMed ID: 20411999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells.
    Flomenberg N; DiPersio J; Calandra G
    Acta Haematol; 2005; 114(4):198-205. PubMed ID: 16269859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plerixafor (Mozobil).
    Med Lett Drugs Ther; 2010 Apr; 52(1335):27-8. PubMed ID: 20360661
    [No Abstract]   [Full Text] [Related]  

  • 17. AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data.
    Calandra G; McCarty J; McGuirk J; Tricot G; Crocker SA; Badel K; Grove B; Dye A; Bridger G
    Bone Marrow Transplant; 2008 Feb; 41(4):331-8. PubMed ID: 17994119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration.
    De Clercq E
    Antivir Chem Chemother; 2019; 27():2040206619829382. PubMed ID: 30776910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New agents for mobilizing peripheral blood stem cells.
    Greinix HT; Worel N
    Transfus Apher Sci; 2009 Aug; 41(1):67-71. PubMed ID: 19615944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program.
    Worel N; Rosskopf K; Neumeister P; Kasparu H; Nachbaur D; Russ G; Namberger K; Witt V; Schloegl E; Zojer N; Linkesch W; Kalhs P; Greinix HT
    Transfusion; 2011 May; 51(5):968-75. PubMed ID: 20880037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.